'Tumor progressing,' 'Positive findings': Patients often confused by medical jargon

by Amy NortonIf you've ever left a medical appointment confused, it's probably not you: A new study finds that the medical jargon doctors use can be completely misunderstood by patients.Common

Updated on: January 22,2024 14

'Tumor progressing,' 'Positive findings': Patients often confused by medical jargon

by Amy NortonIf you've ever left a medical appointment confused, it's probably not you: A new study finds that the medical jargon doctors use can be completely misunderstood by patients.Common

Updated on:January 22,2024 14

Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer

by The Wistar InstituteCredit: The Wistar InstituteWistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for t

Updated on: April 07,2024 19

Repurposing existing FDA-approved inhibitors may provide new treatment approach for ovarian cancer

by The Wistar InstituteCredit: The Wistar InstituteWistar researchers have found rationale for repurposing a class of antitumor compounds called HDAC inhibitors, already approved by the FDA for t

Updated on:April 07,2024 19

Scientists develop potential stealth cancer therapy

by Yale Cancer Center/Smilow Cancer HospitalCredit:ACS Central Science(2024). DOI: 10.1021/acscentsci.4c00559Sneaking by cancer's defenses, by disguising tumor-fighting antibodies insi

Updated on: July 17,2024 0

Scientists develop potential stealth cancer therapy

by Yale Cancer Center/Smilow Cancer HospitalCredit:ACS Central Science(2024). DOI: 10.1021/acscentsci.4c00559Sneaking by cancer's defenses, by disguising tumor-fighting antibodies insi

Updated on:July 17,2024 0

Mathematical methods for diagnosing breast cancer

by Kaunas University of Technology100 microscope images of breast tissue were analyzed in order to teach computer to recognize malignancy; 85 percent accuracy rate was achieved. Credit: KTUA team

Updated on: April 14,2024 20

Mathematical methods for diagnosing breast cancer

by Kaunas University of Technology100 microscope images of breast tissue were analyzed in order to teach computer to recognize malignancy; 85 percent accuracy rate was achieved. Credit: KTUA team

Updated on:April 14,2024 20

Immune system B-cells can help predict HER2-positive breast cancer treatment response

byUNC Lineberger Comprehensive Cancer CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: NCI Ce

Updated on: January 02,2024 9

Immune system B-cells can help predict HER2-positive breast cancer treatment response

byUNC Lineberger Comprehensive Cancer CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: NCI Ce

Updated on:January 02,2024 9

Boosting T cell 'memory' may result in longer-lasting and effective responses for patients

by University of Texas M. D. Anderson Cancer CenterScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDJust like pe

Updated on: April 18,2024 11

Boosting T cell 'memory' may result in longer-lasting and effective responses for patients

by University of Texas M. D. Anderson Cancer CenterScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDJust like pe

Updated on:April 18,2024 11

Possible therapeutic approach to fight incurable blood cancer

by Technical University MunichGraphical abstract. Credit:The EMBO Journal(2022). DOI: 10.15252/embj.2022110871Multiple myeloma (MM) is the second most common type of blood cancer. It

Updated on: January 30,2024 11

Possible therapeutic approach to fight incurable blood cancer

by Technical University MunichGraphical abstract. Credit:The EMBO Journal(2022). DOI: 10.15252/embj.2022110871Multiple myeloma (MM) is the second most common type of blood cancer. It

Updated on:January 30,2024 11

New tool helps find genetic culprits in cancer's spread

by Bill Hathaway,Yale UniversityYale researchers developed a new approach to simultaneously investigate hundreds of mutation combinations for their ability to drive lung metastasis. Credit: Yale

Updated on: March 01,2024 16

New tool helps find genetic culprits in cancer's spread

by Bill Hathaway,Yale UniversityYale researchers developed a new approach to simultaneously investigate hundreds of mutation combinations for their ability to drive lung metastasis. Credit: Yale

Updated on:March 01,2024 16

Study reveals proton beam therapy may shorten breast cancer treatment

by Mayo ClinicCredit: Mayo ClinicIn a randomized trial, published inThe Lancet Oncology,Mayo Clinic Comprehensive Cancer Center researchers uncover evidence supporting a shorter treat

Updated on: January 30,2024 16

Study reveals proton beam therapy may shorten breast cancer treatment

by Mayo ClinicCredit: Mayo ClinicIn a randomized trial, published inThe Lancet Oncology,Mayo Clinic Comprehensive Cancer Center researchers uncover evidence supporting a shorter treat

Updated on:January 30,2024 16

Supercharging immunotherapy to stop breast cancer from spreading to the lung

byUniversity of GlasgowGraphical abstract. Credit:Journal of Experimental Medicine(2022). DOI: 10.1084/jem.20211431Breast cancer immunotherapy could be more effective if an immune ce

Updated on: January 02,2024 8

Supercharging immunotherapy to stop breast cancer from spreading to the lung

byUniversity of GlasgowGraphical abstract. Credit:Journal of Experimental Medicine(2022). DOI: 10.1084/jem.20211431Breast cancer immunotherapy could be more effective if an immune ce

Updated on:January 02,2024 8

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on: January 04,2024 8

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on:January 04,2024 8

New research shows how cancer rewires a key immune pathway to spread

byWeill Cornell Medical CollegeA collaboration between MSK and Weill Cornell Medicine used an approach called ContactTracing to predict the effect of interactions between cells in the tumor micr

Updated on: January 12,2024 12

New research shows how cancer rewires a key immune pathway to spread

byWeill Cornell Medical CollegeA collaboration between MSK and Weill Cornell Medicine used an approach called ContactTracing to predict the effect of interactions between cells in the tumor micr

Updated on:January 12,2024 12